DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 4 filers reported holding DENALI THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARBOR CAPITAL ADVISORS, INC. | 60,304 | $1,294,124 | 0.25% |
| Bartlett & Co. LLC | 1,500 | $33 | 0.00% |
| MASSMUTUAL TRUST CO FSB/ADV | 117 | $2,511 | 0.00% |
| Versant Capital Management, Inc | 8 | $172 | 0.00% |
External links
This page lists DENALI THERAPEUTICS INC's shareholders in Q4 2023. To view DENALI THERAPEUTICS INC's shareholder history, click here.